Status:
UNKNOWN
Hydromorphone for ICU-analgesia in Patients With Non-mechanical Ventilation
Lead Sponsor:
Nanfang Hospital, Southern Medical University
Conditions:
Hydromorphone
Analgesia
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Hydromorphone has a clear analgesic effect, and has few advantages in respiratory depression and gastrointestinal motility. The study will further explore the continuous pumping-dose of hydromorphone ...
Eligibility Criteria
Inclusion
- Age ≥18 years old;
- Non-mechanical ventilation patients with expected ICU stay time \>24h
- People with moderate to severe pain who need immediate analgesic treatment (NRS ≥ 4 or BPS ≥ 5 points, CPOT ≥ 3);
Exclusion
- pregnancy；
- can not get pain score from patients
- allergy to drugs
- ....
Key Trial Info
Start Date :
September 4 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2022
Estimated Enrollment :
530 Patients enrolled
Trial Details
Trial ID
NCT04436224
Start Date
September 4 2020
End Date
September 1 2022
Last Update
January 20 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Southern medical university Nanfang hospital
Guangzhou, China, 510515